Exosens
EXENS.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.97B
Close$
$47.39
16.9% downside
Current Fair Value
16.9% downsideOvervalued by 16.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.97 Billion |
|---|---|
| Enterprise Value | $3.17 Billion |
| Dividend Yield | $0.30 (0.51%) |
| Earnings per Share | $0.84 |
| Beta | 0.84 |
| Outstanding Shares | 50,932,000 |
Return
| Return on Equity | 25.14% |
|---|---|
| Return on Assets | 12.66% |
| Return on Invested Capital | 23.38% |
Valuation & Multiples
| P/E Ratio | 98.98 |
|---|---|
| PEG | -219.09 |
| Price to Sales | 3.17 |
| Price to Book Ratio | 7.13 |
| Enterprise Value to Revenue | 3.42 |
| Enterprise Value to EBIT | 17.74 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$253.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Exosens
2,000 employees
CEO: Jerome Cerisier Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest...